Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fifty 410 vs Lavender Sky Health

Fifty 410
Graded #94

Higher grade

vs+2.5999999999999943
Lavender Sky Health
Graded #138

Lower grade

The verdict

Fifty 410 takes it — 71.3/100 to 68.7/100.

Fifty 410 grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A and 503B…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFifty 410 +10
86
76
Dose & formulationFifty 410 +8
72
64
Clinical oversightFifty 410 +6
80
74
Labs & monitoringEven
53
53
FulfillmentLavender Sky Health +10
71
81
Contract termsLavender Sky Health +18
37
55
Fifty 410 · left barLavender Sky Health · right bar

The numbers

MetricFifty 410Lavender Sky Health
WeighScore71.3/10068.7/100
GradeCC
Scorecard rank#94#138
Semaglutide$99/mo (all doses, compounded)$139/mo (starting dose, month to month, Southend Pharmacy, compounded)
Tirzepatide$133/mo (starting dose, compounded)$149/mo (starting dose, month to month, ReviveRx, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Fifty 410

Graded #94 · C

Strengths

  • Transparent public pricing from 99 dollars per month for semaglutide
  • No membership or subscription; pay only for what you need
  • Compounded by FDA-registered 503A and 503B pharmacies
  • Fast 24 to 48 hour provider review
  • Free one to two day shipping

Where it loses points

  • Does not bill insurance directly
  • Compounded GLP-1 is not an FDA-approved finished drug
  • Specific clinician credentials are not publicly disclosed
  • Served-states list is not published on the site
  • No branded GLP-1 options
Lavender Sky Health

Graded #138 · C

Strengths

  • The treatment-plan pricing page publishes every pharmacy's full ladder rather than one headline figure, so the cheaper prepaid tiers are visible alongside the monthly ones
  • A genuine month-to-month starter plan exists with no prepay, and the cheapest of them is what is filed above — Southend for semaglutide, ReviveRx for tirzepatide
  • Compounded plans include the price of the medication, and shipping and supplies are stated as included
  • Both semaglutide and tirzepatide are offered, across roughly ten named compounding pharmacies

Where it loses points

  • This is a marketplace, not one price: every figure belongs to a named pharmacy on a named plan, and the pharmacy and plan have to travel with the number for it to mean anything
  • Most of the ladder is prepaid — Tier plans need 8-10 weeks up front and Extended plans 3-4 months — and only a handful of the pharmacies publish a month-to-month starter plan at all
  • Brand-name plans add a separate $25 monthly treatment-plan fee and explicitly do not include the price of the medication; only the compounded plans include it
  • No price appears on the homepage, and the pricing page is the only place the ladders are published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard